BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that Thomas (Tom) Pike will join Labcorp as president and chief executive officer of its ...

Predictive Oncology Inc. has announced the successful development of 3D organoid models specifically for Labcorp, which include unique human and rat liver toxicity models. These models are designed to ...

Fortrea will make life-changing innovation possible by combining decades of experience with the nimbleness needed today to improve the drug development process. Fortrea intends to help customers drive ...

Oct 28 (Reuters) - Laboratory services provider Labcorp (LH.N), opens new tab forecast lower annual revenue growth for its contract research unit on Tuesday, as a prolonged funding crunch continues to ...

Firms claim microfluidics-based system will provide early indicator of drug response. LabCorp negotiated rights to market cancer diagnostics firm On-Q-ity’s circulating tumor cell (CTC) platform to ...

April 25 (Reuters) - Laboratory Corp of America Holdings (LH.N), opens new tab missed estimates for quarterly profit on Tuesday, as its drug development unit struggled against curbs on animal imports, ...

Article ‘Count’ and ‘Share’ for Labcorp Drug Development based on listed parameters only. The articles listed below published by authors from Labcorp Drug Development, organized by journal and article ...

The positions in the table below reflect the Labcorp Drug Development's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that the new company to be formed by the planned spin-off of its Clinical Development ...